MaxCyte
MXCT
$4.67
Share price
-2.71%
Change (1 day)
22.57%
Change (1 year)
Categories
Operating Margin for MaxCyte (MXCT)
Operating Margin as of May 2024 (TTM): -53.25%
According to MaxCyte's latest financial reports and stock price the company's current Operating Margin is -53.25%. At the end of 2021 the company had an Operating Margin of -56.30%.
Operating Margin history for MaxCyte from 2021 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -56.30% | 24.68% |
| 2020 | -45.15% | -24.29% |
| 2019 | -59.64% | 12.08% |
| 2018 | -53.21% | -24.96% |
| 2017 | -70.91% | 160.07% |
| 2016 | -27.27% | 75.25% |
| 2015 | -15.56% | -39.32% |
| 2014 | -25.64% | 82.1% |
| 2013 | -14.08% | -64.17% |
| 2012 | -39.30% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.